Private Equity
Relogix, an Ottawa-based sensor-as-a-service provider for workplace performance management, has raised $1.4 million in a seed-stage financing, according to a report by the Ottawa Business Journal. The round was led by Canadian early-stage venture capital firm Mistral Venture Partners, the report said. Relogix, founded in 2010 by CEO Andrew Millar, considers the latest deal to be a top up to a $1.4 million financing closed last year, the report said. The 2017 round was backed by Capital Angels Network and other angels. Relogix's technology uses Internet-of-Things sensors to monitor workspace utilization, workplace design effectiveness, and employee engagement.
1 min read · 09 August 2018
Eventbrite has acquired Picatic, a Vancouver-based online ticketing and event registration platform. No financial terms were disclosed for the deal, which will see Picatic CEO Jayesh Parmar, who helped launch the company in 2008, join Eventbrite. Eventbrite, a U.S. ticketing and event technology platform, said the deal adds technical talent to its workforce and broadens the company's Canadian operations. Founded in 2006, Eventbrite has raised venture capital funding from DAG Ventures, Sequoia Capital, Tiger Global and others. Picatic's investors included BDC Capital, CrossPacific Capital Partners and Extreme Venture Partners.
3 min read · 08 August 2018
MineSense Technologies, a Vancouver-based digital mining solutions provider, has secured $23.5 million (US$18 million) in its latest financing. The round was led by Prelude Ventures and joined by strategic investors Caterpillar Inc, Mitsubishi Corp and new backer ABB Technology Ventures, the venture capital arm of Europe's ABB Group. Existing investors Aurus Ventures, Chrysalix Venture Capital and Cycle Capital Management also participated. MineSense, founded in 2008, provides real-time, sensor-based ore data and sorting solutions for large-scale mines. CEO Jeff More said the funds raised will accelerate the commercialization of the company's digital offering.
3 min read · 08 August 2018
IS5 Communications Inc, a Toronto-based provider of cyber-secure industrial platforms, has closed a $22 million financing. The deal was led by Phoenix Contact Innovation Ventures, the venture capital arm of Germany's Phoenix Contact Group, and joined by U.S. venture capital firm ClearSky and other investors. Founded in 2012 by President and CEO Clive Dias, iS5Com provides integrated services and solutions, and makes intelligent industrial Ethernet products, for a range of sectors. The company will use the funds raised to further enhance its RAPTOR platform and develop solutions for securing critical infrastructure communications and networks.
4 min read · 07 August 2018
AlayaCare, a cloud-based home healthcare software provider, has secured $13.8 million in a Series B financing. Canadian venture capital firm iNovia Capital led the round. As a result, iNovia Principal Magaly Charbonneau will join the board. Other investors in the deal included Chrysalis and Fonds Innovexport. Founded in 2014 by CEO Adrian Schauer, AlayaCare’s platform offers support to home and community care providers, including back office, client and family portals, remote patient monitoring, telehealth and mobile care worker functionality. The Toronto- and Montréal-based company will use the funds raised to continue expanding in the U.S. market and further develop its technology.
3 min read · 07 August 2018
Canadian cannabis investment firm Green Acre Capital has launched its second fund, securing more than $35 million in lead commitments. Green Acre Capital Fund II was backed by Aphria Inc, York Plains Investment Corp, Brett Wilson, Craig Lothian and several other wealthy investors. Like Fund I, which raised $25 million last year, Fund II will invest in early- and growth-stage private companies in the medical and recreational cannabis industry. It will source opportunities in Canada and abroad. Based in Toronto and Calgary, Green Acre Capital is led by Managing Directors Matt Shalhoub and Tyler Stuart.
3 min read · 03 August 2018
Georgian Partners has raised about $715 million (US$550 million) for its fourth growth equity fund, winning a strong vote of confidence from limited partners for the firm’s North American scaling strategy. Georgian Partners Growth Fund IV closed this week at its hard cap, the Toronto investor told PE Hub Canada. The fund, Georgian's largest to date, secured 47 percent more than its predecessor, which raised about $485 million in 2016. It is also one of Canada’s largest private tech partnerships on record, according to Thomson Reuters data.
3 min read · 03 August 2018
Victoria, British Columbia-based cybersecurity company HYAS has raised $6.2 million in a Series A financing. The round was led by M12, the venture capital fund of Microsoft, and joined by Startup Capital Ventures, 205 Capital, Wesley Clover International and cybersecurity professionals Tim Eades and Tom Noonan. Founded in 2015 by CEO Chris Davis, HYAS provides attribution intelligence tools to help information security and cybersecurity professionals identify threats and the criminals behind them. Comox, the company's flagship platform, gives users access to billions of threat indicators. HYAS will use the funds raised to build out its current products and services and develop new technologies.
3 min read · 02 August 2018
Information Venture Partners is seeing a lucrative payday with the US$1.55 billion sale of a Silicon Valley business-planning software provider. Adaptive Insights, backed by Information VP for more than a decade, was sold this week to Workday. The deal gave the Toronto venture firm about 10x its investment, a person with knowledge of the matter told PE Hub Canada. Information VP declined comment. Adaptive is one of several major liquidity events Information VP completed in recent months.
3 min read · 02 August 2018
Angiochem Inc, a Montréal-based clinical-stage biotechnology company, has secured $7.5 million in a Series C financing. The round's investors were not disclosed. Angiochem has previously raised financing from BDC Capital's Healthcare Venture Fund, the life sciences group of Vimac Ventures, and other sources. Angiochem said the funds raised will be used to support development of ANG1005. The compound is intended to treat leptomeningeal carcinomatosis from breast cancer, for which there are no therapeutic options at present. Founded in 2003, Angiochem is developing a product pipeline for the treatment of a range of central nervous system diseases.
2 min read · 01 August 2018
